Funds with similar focus
Fund Name | Location |
Achain | Beijing, Beijing, China |
AKAKIYA HOLDINGS | Japan, Tokyo |
Alisamiah Investment | - |
Brigade Group | Bangalore, India, Karnataka |
Cogito Capital Partners | Luxembourg, Luxembourg |
Crane Group | - |
Data Applications | Japan, Tokyo |
Eurostars | Belgium, Brussels, Brussels Hoofdstedelijk Gewest |
Fangde Zhilian Investment | China, Guangdong, Shenzhen |
Investo | Distrito Federal, Mexico, Mexico City |
JJ Albanese | California, Santa Clara, United States |
Numis Securities | England, London, United Kingdom |
Pario Ventures | - |
TomyK | Chiyoda, Japan |
TripLabs Limited | China, Hong Kong, Hong Kong Island |
VentureTech Alliance | California, San Jose, United States |
Zhongde Technology | China, Hohhot, Nei Mongol |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
VivaVision Biotech | $10M | 26 Sep 2019 | Shanghai, China | ||
Huisuanzhang | $30M | 24 Oct 2017 | Dongcheng District, Beijing, China | ||
Huisuanzhang | $23M | 29 Dec 2016 | Dongcheng District, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
VivaVision Biotech | $10M | 26 Sep 2019 | Shanghai, China | ||
Huisuanzhang | $30M | 24 Oct 2017 | Dongcheng District, Beijing, China | ||
Huisuanzhang | $23M | 29 Dec 2016 | Dongcheng District, Beijing, China |